Skip to content
Medicines & Healthcare products Regulatory Agency
The National Institute for Biological Standards and Control

Confidence in biological medicines

  • Stay connected
  • Shopping Basket
  • Pay Now
  • Login / Register
  • Home
  • Products
  • Standardisation
  • Control testing
  • Science and research
  • Expert services
  • About us
  • Advanced therapies
  • Virology
  • Diagnostics
  • Biotherapeutics
  • Bacteriology
  • Analytical sciences
  • A to Z listing
  • Publications
  • Home  /  
  • Science and research  /  
  • Biotherapeutics  /  
  • Nanobodies  /  
  • Influenza B (Victoria and Yamagata lineages)

Influenza B (Victoria and Yamagata lineages)

Single-domain antibodies (VHH nanobodies) generated from immunised alpacas. The panel comprises cross-reactive and lineage-specific nanobodies.

Some of these nanobodies are featured in the following publication.

Ramage W, Gaiotto T, Ball C, Risley P, Carnell GW, Temperton N, Cheung CY, Engelhardt OG, Hufton SE. Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin. Antibodies (Basel). 2019 Feb 10;8(1):14. doi: 10.3390/antib8010014. 

For enquiries visit: Non-Exclusive Licensing Enquiry Form for Nanobodies

 
  • Careers
  • Terms and conditions
  • Accessibility
  • Privacy notice
  • Cookies
  • Sitemap